BETRF (BetterLife Pharma) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Oct. 2024)

View and export this data going back to 2010. Start your Free Trial

What is BetterLife Pharma Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

BetterLife Pharma's net issuance of preferred for the three months ended in Oct. 2024 was $0.00 Mil. The number is 0, which means that BetterLife Pharma has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

BetterLife Pharma's net issuance of preferred for the trailing twelve months (TTM) ended in Oct. 2024 was $0.00 Mil.

BetterLife Pharma Net Issuance of Preferred Stock Historical Data

The historical data trend for BetterLife Pharma's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Net Issuance of Preferred Stock Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

BetterLife Pharma Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

BetterLife Pharma Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

BetterLife Pharma Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (OTCPK:BETRF) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

NPAU:Germany NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

Executives

Barbara-jean Anne Bormann-kennedy	director, officer: President	1188 BROADWAY, SUITE 306, SOMERVILLE MA 02144
Moira Ong	officer: Chief Financial Officer	2392 LAWSON AVENUE, WEST VANCOUVER A1 V7V 2E6
Hassan Salari	director, 10 percent owner	1517 WEST 58TH AVENUE, VANCOUVER A1 V6P 1W6
Ahmad Doroudian	director, officer: Chairman	1275 WEST 6TH AVENUE, VANCOUVER A1 V6H 1A6